Wuhan lab staff sought hospital care before COVID-19 outbreak disclosed: Report

The newspaper said the report - which provides fresh details on the number of researchers affected, the timing of their illnesses, and their hospital visits - may add weight to calls for a broader probe of whether the COVID-19 virus could have escaped from the laboratory.

Reuters
May 24, 2021 / 08:25 AM IST

(Image: Reuters)

Three researchers from China's Wuhan Institute of Virology (WIV) sought hospital care in November 2019, months before China disclosed the COVID-19 pandemic, the Wall Street Journal reported on Sunday, citing a previously undisclosed U.S. intelligence report.

The newspaper said the report - which provides fresh details on the number of researchers affected, the timing of their illnesses, and their hospital visits - may add weight to calls for a broader probe of whether the COVID-19 virus could have escaped from the laboratory.

The report came on the eve of a meeting of the World Health Organization's decision-making body, which is expected to discuss the next phase of an investigation into the origins of COVID-19.

A National Security Council spokeswoman had no comment on the Journal's report but said the Biden administration continued to have "serious questions about the earliest days of the COVID-19 pandemic, including its origins within the Peoples Republic of China."

She said the U.S. government was working with the WHO and other member states to support an expert-driven evaluation of the pandemic's origins "that is free from interference or politicization."

Clos

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"We're not going to make pronouncements that prejudge an ongoing WHO study into the source of SARS-CoV-2, but we've been clear that sound and technically credible theories should be thoroughly evaluated by international experts," she said.

The Journal said current and former officials familiar with the intelligence about the lab researchers expressed a range of views about the strength of the report's supporting evidence, with one unnamed person saying it needed "further investigation and additional corroboration."

The United States, Norway, Canada, Britain and other countries in March expressed concerns about the WHO-led COVID-19 origins study, and called for further investigation and full access to all pertinent human, animal and other data about the early stages of the outbreak.

Washington is keen to ensure greater cooperation and transparency by China, according to a source familiar with the effort.

The Chinese Embassy in Washington did not immediately respond to a request for comment on Sunday.

On Sunday, China's foreign ministry noted that a WHO-led team had concluded a lab leak was extremely unlikely after a visit in February to the virology institute. "The U.S. continues to hype the lab leak theory," the ministry said in response to a request for comment by the Journal. "Is it actually concerned about tracing the source or trying to divert attention?"

The Trump administration had said it suspected the virus may have escaped from a Chinese lab, which Beijing denies.

A State Department fact sheet released near the end of the Trump administration had said "the U.S. government has reason to believe that several researchers inside the WIV became sick in autumn 2019, before the first identified case of the outbreak, with symptoms consistent with both COVID-19 and common seasonal illnesses." It did not say how many researchers.

China refused to give raw data on early COVID-19 cases to the WHO-led team probing the origins of the pandemic, according to one of the team’s investigators, Reuters reported in February, potentially complicating efforts to understand how the outbreak began.
Reuters
TAGS: #China #coronavirus #Covid-19 #World News #Wuhan
first published: May 24, 2021 08:14 am